HomeSUPN • NASDAQ
add
Supernus Pharmaceuticals Inc
Previous close
$28.87
Day range
$28.67 - $29.51
Year range
$21.99 - $39.09
Market cap
1.61B USD
Avg Volume
429.48K
P/E ratio
1,243.36
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 164.31M | -1.80% |
Operating expense | 125.70M | 11.79% |
Net income | 1.18M | -95.39% |
Net profit margin | 0.71 | -95.34% |
Earnings per share | 0.89 | 30.55% |
EBITDA | 40.66M | -22.95% |
Effective tax rate | -18.69% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 254.87M | -44.75% |
Total assets | 1.28B | -24.95% |
Total liabilities | 356.16M | -56.37% |
Total equity | 921.52M | — |
Shares outstanding | 54.73M | — |
Price to book | 1.71 | — |
Return on assets | 3.70% | — |
Return on capital | 4.95% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 1.18M | -95.39% |
Cash from operations | 44.96M | 63.10% |
Cash from investing | -65.98M | -35.30% |
Cash from financing | 1.09M | -61.40% |
Net change in cash | -19.93M | -8.49% |
Free cash flow | 53.77M | 7,748.38% |
About
Founded
2005
Headquarters
Website
Employees
652